IONEXCHANG ION Exchange (India) Q4 FY26 results (Jan–Mar 2026) and concall
Ion Exchange reported a 7% YoY increase in FY26 operating income to INR 2,914.8 crores, but EBITDA saw a 29% YoY decline to INR 210.2 crores, with margins compressing to 7.21%. Q4 performance was notably impacted by the West Asia crisis, leading to deferred engineering shipments and affecting chemical segment profitability due to input costs and Roha facility expenses. Despite these challenges, the company secured a strong engineering order book of INR 2,643.3 crores, expanded its international footprint, and made strategic advancements in membrane technology through a partnership with MANN+HU
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 3.7%, net profit down 69.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 589 | 650 | 785 | 518 | 678 +15% | 669 +3% | 814 +4% |
| EBITDA | 67 | 74 | 83 | 56 | 61 −9% | 56 −24% | 11 −87% |
| Net profit | 51 | 53 | 65 | 47 | 48 −6% | 24 −55% | 20 −69% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
